Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine von Peak, Corey M, Lyons, Hil, Voorman, Arend, Gray, Elizabeth J, Cooper, Laura V, Blake, Isobel M, Hawes, Kaija M, Bandyopadhyay, Ananda S

Volltext

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021 von Martin, Javier, Burns, Cara C, Jorba, Jaume, Shulman, Lester M, Macadam, Andrew, Klapsa, Dimitra, Majumdar, Manasi, Bullows, James, Frolov, Ann, Mate, Ryan, Bujaki, Erika, Castro, Christina J, Bullard, Kelley, Konz, John, Hawes, Kaija, Gauld, Jillian, Blake, Isobel M, Mercer, Laina D, Kurji, Feyrouz, Voorman, Arie, Diop, Ousmane M, Oberste, M Steven, Modlin, John, Macklin, Grace, Eisenhawer, Martin, Bandyopadhyay, Ananda S, Zipursky, Simona

Volltext

Notes from the Field : Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023 von Davlantes, Elizabeth, Jorba, Jaume, Henderson, Elizabeth, Bullard, Kelley, Deka, Mark. A., Kfutwah, Anfumbom, Martin, Javier, Bessaud, Maël, Shulman, Lester M., Hawes, Kaija, Diop, Ousmane M., Bandyopadhyay, Ananda S., Zipursky, Simona, Burns, Cara C.

Volltext

Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use--Six African Countries, 2021-2023 von Davlantes, Elizabeth, Jorba, Jaume, Henderson, Elizabeth, Bullard, Kelley, Deka, Mark. A, Kfutwah, Anfumbom, Martin, Javier, Bessaud, Mael, Shulman, Lester M, Hawes, Kaija, Diop, Ousmane M, Bandyopadhyay, Ananda S, Zipursky, Simona, Burns, Cara C

Volltext

Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under emergency use listing--worldwide, March-October 2021/Caracterisation genetique de... von Martin, Javier, Burns, Cara C, Jorba, Jaume, Shulman, Lester M, Macadam, Andrew, Klapsa, Dimitra, Majumdar, Manasi, Bullows, James, Frolov, Ann, Mate, Ryan, Bujaki, Erika, Castro, Christina J, Bullard, Kelley, Konz, John, Hawes, Kaija, Gauld, Jillian, Blake, Isobel M, Mercer, Laina D, Kurji, Feyrouz, Voorman, Arie, Diop, Ousmane M, Oberste, Steven, Modlin, John, Macklin, Grace, Eisenhawer, Martin, Bandyopadhyay, Ananda S, Zipursky, Simona

Volltext

Genetic characterization of novel oral polio vaccine type 2 viruses during initial use phase under emergency use listing – worldwide, March–October 2021 von Martin, Javier, Burns, Cara C, Jorba, Jaume, Shulman, Lester M, Macadam, Andrew, Klapsa, Dimitra, Majumdar, Manasi, Bullows, James, Frolov, Ann, Mate, Ryan, Bujaki, Erika, Castro, Christina J, Bullard, Kelley, Konz, John, Hawes, Kaija, Gauld, Jillian, Blake, Isobel M, Mercer, Laina D, Kurji, Feyrouz, Voorman, Arie, Diop, Ousmane M, Oberste, Steven, Modlin, John, Macklin, Grace, Eisenhawer, Martin, Bandyopadhyay, Ananda S, Zipursky, Simona

Volltext